P626 Deletion of toll-like receptor 9 aggravates diastolic heart failure induced by serca2a ablation.

Autor: Holmen, YD, Sjaastad, I, Yndestad, A, Finsen, AV, Ranheim, T, Alfsnes, K, Gullestad, L, Aukrust, P, Christensen, G, Vinge, LE

Publikováno v: Cardiovascular Research; Jul2014, Vol. 103 Issue suppl_1, pS113-S114, 1p

Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension.

Autor: Ohm IK; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway; Center for Heart Failure Research, University of Oslo, Oslo, Norway., Gao E; Center for Translational Medicine, School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America., Belland Olsen M; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Center for Heart Failure Research, University of Oslo, Oslo, Norway., Alfsnes K; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Bliksøen M; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Center for Heart Failure Research, University of Oslo, Oslo, Norway., Øgaard J; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Ranheim T; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Center for Heart Failure Research, University of Oslo, Oslo, Norway., Nymo SH; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway; Center for Heart Failure Research, University of Oslo, Oslo, Norway., Holmen YD; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Center for Heart Failure Research, University of Oslo, Oslo, Norway., Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway; K.G. Jebsen Inflammatory Research Center, University of Oslo, Oslo, Norway., Yndestad A; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway; Center for Heart Failure Research, University of Oslo, Oslo, Norway; K.G. Jebsen Inflammatory Research Center, University of Oslo, Oslo, Norway., Vinge LE; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Center for Heart Failure Research, University of Oslo, Oslo, Norway; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway; K.G. Jebsen Cardiac Research Center, University of Oslo, Oslo, Norway.

Publikováno v: PloS one [PLoS One] 2014 Aug 15; Vol. 9 (8), pp. e104407. Date of Electronic Publication: 2014 Aug 15 (Print Publication: 2014).